For many Americans, the calamitously slow vaccine roll-out in countries like Germany, France, and Italy comes as a surprise. After all, in the early days of the pandemic, Europe’s response to the crisis seemed highly competent, especially compared to the United States.
But the sluggish vaccination campaign in these nations is actually quite predictable. For years, European policymakers have imposed strict price controls on new pharmaceuticals – and those price caps have delayed patients’ access to cutting-edge medicines. The same story is now playing out with Covid-19 vaccines. Read More Here >>